openPR Logo
Press release

China Emphysema Treatment Market Outlook, Trend, Overview, Shares and Key Players are Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals

01-04-2022 11:36 AM CET | Health & Medicine

Press release from: ReportsnReports

The China Emphysema Treatment Market research report includes the competitive landscape that involves leading companies and adopting strategies to introduce new products, announce partnerships, and collaborate to contribute to market growth. Moreover, the report elaborates on numerous customers’ journeys related to this industry, regions, and segments. The China Emphysema Treatment Market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions.

Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5229574

China Emphysema Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Emphysema Treatment Market Segment Percentages, By Type, 2020 (%)
- Centrilobular emphysema
- Panlobular emphysema

China Emphysema Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Emphysema Treatment Market Segment Percentages, By Application, 2020 (%)
- Hospital
- Clinics
- Surgical center

Competitor Analysis

The report also provides analysis of leading market participants including:
Key companies Emphysema Treatment revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Emphysema Treatment revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:

- Pulmonx
- Bioxyne
- Intrexon
- Icure Pharmaceuticals
- Kamada
- Emphasys Medical
- Pfizer
- Olympus
- BTG
- PneumRx and Uptake Medical
- Halozyme Therapeutics
- Mariposa Health
- Uptake Medical

The China Emphysema Treatment Market research report help builds up a clear view of the market trends and development, identify major players in the industry and estimate main downstream sectors. Moreover, the China Emphysema Treatment Market research report examines competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the China Emphysema Treatment Market.

Purchase this report (FLAT 20% Discount. Coupon Code: JAN20) at: https://www.reportsnreports.com/purchase.aspx?name=5229574

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Emphysema Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Emphysema Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Emphysema Treatment Overall Market Size
2.1 China Emphysema Treatment Market Size: 2021 VS 2027
2.2 China Emphysema Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Emphysema Treatment Players in China Market
3.2 Top China Emphysema Treatment Companies Ranked by Revenue
3.3 China Emphysema Treatment Revenue by Companies
3.4 Top 3 and Top 5 Emphysema Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Emphysema Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Emphysema Treatment Players in China Market
3.6.1 List of Tier 1 Emphysema Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Emphysema Treatment Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Emphysema Treatment Market Size Markets, 2021 & 2027
4.1.2 Centrilobular emphysema
4.1.3 Panlobular emphysema
4.2 By Type - China Emphysema Treatment Revenue & Forecasts
4.2.1 By Type - China Emphysema Treatment Revenue, 2016-2021
4.2.2 By Type - China Emphysema Treatment Revenue, 2022-2027
4.2.3 By Type - China Emphysema Treatment Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Emphysema Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Surgical center
5.2 By Application - China Emphysema Treatment Revenue & Forecasts
5.2.1 By Application - China Emphysema Treatment Revenue, 2016-2021
5.2.2 By Application - China Emphysema Treatment Revenue, 2022-2027
5.2.3 By Application - China Emphysema Treatment Revenue Market Share, 2016-2027

6 Emphysema Treatment Companies Profiles
6.1 Pulmonx
6.1.1 Pulmonx Company Details
6.1.2 Pulmonx Business Overview
6.1.3 Pulmonx Emphysema Treatment Introduction
6.1.4 Pulmonx Emphysema Treatment Revenue in China Market (2016-2021)
6.1.5 Pulmonx Recent Developments
6.2 Bioxyne
6.2.1 Bioxyne Company Details
6.2.2 Bioxyne Business Overview
6.2.3 Bioxyne Emphysema Treatment Introduction
6.2.4 Bioxyne Emphysema Treatment Revenue in China Market (2016-2021)
6.2.5 Bioxyne Recent Developments
6.3 Intrexon
6.3.1 Intrexon Company Details
6.3.2 Intrexon Business Overview
6.3.3 Intrexon Emphysema Treatment Introduction
6.3.4 Intrexon Emphysema Treatment Revenue in China Market (2016-2021)
6.3.5 Intrexon Recent Developments
6.4 Icure Pharmaceuticals
6.4.1 Icure Pharmaceuticals Company Details
6.4.2 Icure Pharmaceuticals Business Overview
6.4.3 Icure Pharmaceuticals Emphysema Treatment Introduction
6.4.4 Icure Pharmaceuticals Emphysema Treatment Revenue in China Market (2016-2021)
6.4.5 Icure Pharmaceuticals Recent Developments
6.5 Kamada
6.5.1 Kamada Company Details
6.5.2 Kamada Business Overview
6.5.3 Kamada Emphysema Treatment Introduction
6.5.4 Kamada Emphysema Treatment Revenue in China Market (2016-2021)
6.5.5 Kamada Recent Developments
6.6 Emphasys Medical
6.6.1 Emphasys Medical Company Details
6.6.2 Emphasys Medical Business Overview
6.6.3 Emphasys Medical Emphysema Treatment Introduction
6.6.4 Emphasys Medical Emphysema Treatment Revenue in China Market (2016-2021)
6.6.5 Emphasys Medical Recent Developments
6.7 Pfizer
6.7.1 Pfizer Company Details
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Emphysema Treatment Introduction
6.7.4 Pfizer Emphysema Treatment Revenue in China Market (2016-2021)
6.7.5 Pfizer Recent Developments
6.8 Olympus
6.8.1 Olympus Company Details
6.8.2 Olympus Business Overview
6.8.3 Olympus Emphysema Treatment Introduction
6.8.4 Olympus Emphysema Treatment Revenue in China Market (2016-2021)
6.8.5 Olympus Recent Developments
6.9 BTG
6.9.1 BTG Company Details
6.9.2 BTG Business Overview
6.9.3 BTG Emphysema Treatment Introduction
6.9.4 BTG Emphysema Treatment Revenue in China Market (2016-2021)
6.9.5 BTG Recent Developments
6.10 PneumRx and Uptake Medical
6.10.1 PneumRx and Uptake Medical Company Details
6.10.2 PneumRx and Uptake Medical Business Overview
6.10.3 PneumRx and Uptake Medical Emphysema Treatment Introduction
6.10.4 PneumRx and Uptake Medical Emphysema Treatment Revenue in China Market (2016-2021)
6.10.5 PneumRx and Uptake Medical Recent Developments
6.11 Halozyme Therapeutics
6.11.1 Halozyme Therapeutics Company Details
6.11.2 Halozyme Therapeutics Business Overview
6.11.3 Halozyme Therapeutics Emphysema Treatment Introduction
6.11.4 Halozyme Therapeutics Emphysema Treatment Revenue in China Market (2016-2021)
6.11.5 Halozyme Therapeutics Recent Developments
6.12 Mariposa Health
6.12.1 Mariposa Health Company Details
6.12.2 Mariposa Health Business Overview
6.12.3 Mariposa Health Emphysema Treatment Introduction
6.12.4 Mariposa Health Emphysema Treatment Revenue in China Market (2016-2021)
6.12.5 Mariposa Health Recent Developments
6.13 Uptake Medical
6.13.1 Uptake Medical Company Details
6.13.2 Uptake Medical Business Overview
6.13.3 Uptake Medical Emphysema Treatment Introduction
6.13.4 Uptake Medical Emphysema Treatment Revenue in China Market (2016-2021)
6.13.5 Uptake Medical Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer

Enquire Here for, Report Enquiry, Discount and Customization at: https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=5229574

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Emphysema Treatment Market Outlook, Trend, Overview, Shares and Key Players are Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals here

News-ID: 2516659 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Emphysema

Emphysema Market: A Comprehensive Overview
Emphysema is a chronic lung disease that primarily affects the alveoli, or air sacs, in the lungs. It is one of the key components of chronic obstructive pulmonary disease (COPD), characterized by progressive difficulty in breathing due to damage to the air sacs, leading to reduced oxygen exchange. The global burden of emphysema is increasing, with more people being diagnosed as the aging population grows and environmental factors like smoking
Emphysema Treatment Market Overview 2024-2033 - Share, Trends, Demand, Outlook
"The new report published by The Business Research Company, titled ""Emphysema Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth The rise in the prevalence
Emphysema Market: Global Industry Analysis and Forecast (2024-2030)
Emphysema Market to Hit USD 6.32 Bn at a growth rate of 4.28 percent- Says Stellar Market Research The Emphysema Market size of the North America region is expected to dominate the market during the forecast period. The Emphysema Market is segmented into By Type, By Treatment, and By Distribution Channel for a better understanding of the market structure. Stellar Market Research, a Healthcare business consultancy and research firm has published
Navigating the Emphysema Treatment Market: Growth, Trends, and Size
Emphysema is a chronic obstructive pulmonary disease (COPD) characterized by the progressive destruction of the air sacs in the lungs, leading to reduced lung function and severe breathing difficulties. This condition is primarily caused by long-term exposure to irritants such as tobacco smoke, air pollution, and occupational dust and chemicals. As a result, the emphysema treatment market has emerged as a critical component of respiratory healthcare. Emphysema patients experience symptoms like
Emphysema Drug Market Will Generate Record Revenue by 2029
The Emphysema Drug Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Emphysema is also referred as chronic obstructive disorder because inhalation and exhalation are slowed down due to over inflammation of alveoli. Emphysema can cause damage to air sac which results in change of shape of air sac or often destruction resulting in low gas exchanged in the lungs leading
Worldwide Emphysema Market 2018 | Emphysema cases are High in Middle East, China …
Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the